Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI
Joint Authors
Haider, Lukas
Trauner, Michael
Mandorfer, Mattias
Güngören, Zeynep
Reiberger, Thomas
Bastati, Nina
Hodge, Jacqueline C.
Chromy, David
Herold, Christian
Peck-Radosavljevic, Markus
Ba-Ssalamah, Ahmed
Source
Contrast Media & Molecular Imaging
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-07-12
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
We evaluated changes in relative liver enhancement (RLE) obtained by gadoxetic acid-enhanced MRI (GA-MRI) in the hepatobiliary phase and changes in splenic volume (SV) after hepatitis C virus (HCV) eradication as well as their predictive value for the development of (further) hepatic decompensation during follow-up.
This retrospective study comprised 31 consecutive patients with HCV-induced advanced chronic liver disease who underwent GA-MRI before and after successful interferon-free treatment, as well as a cohort of 14 untreated chronic HCV-patients with paired GA-MRI.
RLE increased by 66% (20%–94%; P<0.001) from pre- to posttreatment, while SV decreased by −16% (−28% to −8%; P<0.001).
However, SV increased in 16% (5/31) of patients, the identical subjects who showed a decrease in RLE (GA-MRI-nonresponse).
We observed an inverse correlation between the changes in RLE and SV (ρ=−0.608; P<0.001).
In the untreated patients, there was a decrease in RLE by −11% (−25% to −3%; P=0.019) and an increase in SV by 23% (7%–43%; P=0.004) (both P<0.001 versus treated patients).
Interestingly, GA-MRI-nonresponse was associated with a substantially increased risk of (further) hepatic decompensation 2 years after the end of treatment: 80% versus 8%; P<0.001.
GA-MRI might distinguish between individuals at low and high risk of (further) hepatic decompensation (GA-MRI-nonresponse) after HCV eradication.
This could allow for individualized surveillance strategies.
American Psychological Association (APA)
Haider, Lukas& Mandorfer, Mattias& Güngören, Zeynep& Reiberger, Thomas& Bastati, Nina& Hodge, Jacqueline C.…[et al.]. 2018. Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI. Contrast Media & Molecular Imaging،Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1131589
Modern Language Association (MLA)
Haider, Lukas…[et al.]. Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI. Contrast Media & Molecular Imaging No. 2018 (2018), pp.1-9.
https://search.emarefa.net/detail/BIM-1131589
American Medical Association (AMA)
Haider, Lukas& Mandorfer, Mattias& Güngören, Zeynep& Reiberger, Thomas& Bastati, Nina& Hodge, Jacqueline C.…[et al.]. Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI. Contrast Media & Molecular Imaging. 2018. Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1131589
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1131589